Sep 14, 2020 / 02:30PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. I'm pleased to have Biogen with me for the next session.
Just briefly before we get started, I need to read a quick disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately. For important disclosures, please see Morgan Stanley research disclosures website at morganstanley.com/researchdisclosures, and reach out to your Morgan Stanley sales rep, if you need anything.
So with me, I have Michel Vounatsos, who's the CEO; as well as Mike McDonnell, who is the new CFO. And Michel, I'm going to turn it over to you for some opening remarks, and then we will get started.
Michel Vounatsos - Biogen Inc. - CEO & Director
Thank you, Matthew.
Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers